Literature DB >> 11673029

Lamotrigine plasma levels reduced by oral contraceptives.

A Sabers1, J M Buchholt, P Uldall, E L Hansen.   

Abstract

Although it is known that the use of oral contraceptives (OC's) can induce glucuronide conjugating enzymes, currently no data exists as to the potential that the elimination of the glucuronidated drug lamotrigine (LTG) is increased by OC's. We present seven cases in whom the plasma levels of LTG were significantly decreased by OC's (mean 49%, range 41-64%). The interaction was of clinical relevance in most of the patients who either experienced increased seizure frequency/recurrence of seizures after OC's had been added, or adverse effects following withdrawal of OC's.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673029     DOI: 10.1016/s0920-1211(01)00305-9

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  32 in total

Review 1.  Taking over epilepsy from the paediatric neurologist.

Authors:  Philip E M Smith; Sheila J Wallace
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

Review 2.  [Lamotrigine in women with epilepsy. Review of present data].

Authors:  B Schmitz
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

3.  More than medication-achieving psychotherapy goals in patients with bipolar disorder in challenging settings.

Authors:  Brenda J B Roman; Paulette Marie Gillig
Journal:  Psychiatry (Edgmont)       Date:  2006-03

4.  Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs.

Authors:  Ruth Ackers; Macey L Murray; Frank M C Besag; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2007-01-25       Impact factor: 4.335

5.  The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.

Authors:  Jagdev Sidhu; Sarah Job; Sunita Singh; Richard Philipson
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

6.  Hormones, seizures, and lamotrigine: Oh, my!

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2008 Jan-Feb       Impact factor: 7.500

Review 7.  [Therapeutic drug monitoring in epileptology and psychiatry].

Authors:  C Brandt; P Baumann; G Eckermann; C Hiemke; T W May; B Rambeck; B Pohlmann-Eden
Journal:  Nervenarzt       Date:  2008-02       Impact factor: 1.214

Review 8.  Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.

Authors:  Valérie A Damoiseaux; Johannes H Proost; Vincent C R Jiawan; Barbro N Melgert
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

9.  Lamotrigine pharmacokinetic evaluation in epileptic patients submitted to VEEG monitoring.

Authors:  A M Almeida; A C Falcão; F Sales; I Baldeiras; M J Rocha; M M Caramona
Journal:  Eur J Clin Pharmacol       Date:  2006-07-27       Impact factor: 2.953

Review 10.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.